Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 80,212 | 24,868 | 23,475 | 13,910 | 10,382 |
| Operating Income | -80,212 | -24,868 | -23,475 | -13,910 | -10,382 |
| Other Income | 3,596 | 3,014 | 2,077 | 2,614 | -479 |
| Pre-tax Income | -76,616 | -21,854 | -21,398 | -11,296 | -10,861 |
| Net Income Continuous | -76,616 | -21,854 | -21,398 | -11,296 | -10,861 |
| Net Income | $-76,616 | $-21,854 | $-21,398 | $-11,296 | $-10,861 |
| EPS Basic Total Ops | -1.83 | -0.57 | -0.59 | 0.28 | -0.95 |
| EPS Basic Continuous Ops | -1.83 | -0.57 | -0.59 | 0.28 | -0.95 |
| EPS Diluted Total Ops | -1.83 | -0.57 | -0.59 | 0.28 | -0.95 |
| EPS Diluted Continuous Ops | -1.83 | -0.57 | -0.59 | 0.28 | -0.95 |
| EPS Diluted Before Non-Recurring Items | -1.83 | -0.57 | -0.59 | N/A | N/A |
| EBITDA(a) | $-79,712 | $-24,374 | $-22,985 | $-13,421 | $-9,892 |